Clinical Trials Logo

Clinical Trial Summary

The investigators hypothesize that perioperative oral administration of pregabalin would reduce postoperative pain and produce reduction in postoperative opioid consumption after anterior cruciate ligament (ACL) reconstruction . Patients are randomly assign to 1 of 2 groups. The placebo group receive placebo capsules 1 hour before surgery and 12 hours after initial dose. The pregabalin group receive pregabalin 150 mg, respectively at the same points.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03211728
Study type Interventional
Source Yonsei University
Contact
Status Completed
Phase N/A
Start date July 19, 2017
Completion date February 8, 2019

See also
  Status Clinical Trial Phase
Completed NCT03417479 - Gabapentin Premedication for ACL Reconstruction: RCT
Withdrawn NCT03562299 - OrthoPureā„¢ XT Pilot Clinical Study N/A
Recruiting NCT04462458 - M-ARS ACL Post-marketing Surveillance Study
Recruiting NCT06382324 - The Psychological Impact of Mindfulness Intervention to Anterior Cruciate Ligament Reconstruction N/A
Recruiting NCT06347523 - VR-Based Preoperative Rehabilitation Program for Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction N/A